Clinical Trials Sponsored by Experior S.L.

Total 3046 results

Superior University

Enrolling by invitation

Comparison of Static Stretching and Deep Kneading Massage Among Plantar Fasciitis Patients

Plantar Fasciitis

Pakistan
Aboca Spa Societa' Agricola
Latis S.r.l.; Eclisse - Euromed Clinical Supply Services Srl; Ceinge - Biotecnologie... and other collaborators

Completed

Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months

Chronic Functional Constipation

Italy
Fundacion Profesor Novoa Santos
ODDS , S.L.; Vifor Pharma España, S.L.

Completed

Feasibility of Implementation of Recommended Standards in Patients With Heart Failure (HFOutcomesSP)

Heart Failure

Spain
PT. Innovative Pharma Solutions
Archivel Farma S.L.; RUTI Immunotherapeutics S.L.

Withdrawn

A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

COVID-19
Institut Català d'Oncologia
AstraZeneca; BioClever 2005 S.L.; VCN Biosciences, S.L.

Active, not recruiting

Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

Recurrence | Head and Neck Neoplasms | Metastasis | Carcinoma, Squamous Cell of Head and Neck

Spain
Fundació Eurecat
Circe, S.L.

Not yet recruiting

Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2) (BIOPTERO2)

Biological Availability

Spain
Rob Surgical Systems S.L.

Active, not recruiting

Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP

Nephrectomy | Prostatectomy

Spain
Procare Health Iberia S.L.

Withdrawn

Study to Evaluate the Effectiveness and Safety of Libicare® in Women With Low Arousal and Sexual Desire Levels (VITAL)

Female Sexual Interest/Arousal Disorder

Spain
Fundació Eurecat
URIACH, S.L.

Completed

Oral Bioavailability of Two Melatonin Supplements (MELFENIL)

Bioavailability

Spain
Mesoestetic Pharma Group S.L.

Completed

Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

Facial Rejuvenation

Bulgaria
Raman Health Technologies, S.L.

Completed

Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease (RH-VAL)

Alzheimer Disease

Spain, Belgium, France
Arrhythmia Network Technology S.L.

Terminated

Sleep Apnea Screening

Sleep Apnea/Hypopnea Syndrome

Spain
ISDIN
Digna Biotech S.L.

Completed

Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis

Skin Fibrosis

Spain, United Kingdom, Germany, Poland, Hungary, Italy
Pentixapharm AG
Pivotal S.L.

Not yet recruiting

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma (LYMFOR)

Marginal Zone Lymphoma
IDP Discovery Pharma S.L.

Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies (CASSANDRA)

Chronic Lymphocytic Leukemia (CLL) | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Multiple Myeloma (MM) | High Grade B-Cell Lymphoma, Not Otherwise Specified | Double Hit Lymphoma | Triple Hit Lymphoma

Spain
Loughborough University
Biopolis S.L.

Recruiting

The Effect of Probiotics on Exercise Performance and Recovery

Probiotics | Acute Exercise

United Kingdom
Ebers Medical Technology, S.L.

Recruiting

Ex Vivo Normothermic Perfusion in Kidney Transplantation. (KidneyARK)

Kidney Transplantation

Spain
Biomedal S.L.
FUNDACION IHP

Suspended

Use of a Home Test for Gluten Detection in Urine and Its Effect on Gluten-free Diet Adherence

Adolescent | Celiac Disease | Treatment Adherence

Spain
Procare Health Iberia S.L.

Completed

Evaluate Clinical Benefit of Local Treatment With KD Intra-Articular® Gel in Patients With Osteoarthritis (NO-DOLOR2) (NO-DOLOR2)

Osteoarthritis, Hip | Osteoarthritis Thumb | Osteoarthritis Ankle

Spain
Gala Servicios Clinicos S.L.

Completed

Oral Supplementation With Active Collagen Peptides and Skin Health Improvement

Facial Wrinkles | Skin Hydration

Spain
Mikrobiomik Healthcare Company S.L.

Completed

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Recurrent Clostridium Difficile Infection | Primary Clostridium Difficile Infection

Spain
Procare Health Iberia S.L.

Completed

Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy (IDRA)

Vulvovaginal Atrophy

Spain
Procare Health Iberia S.L.

Completed

Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV (PAPILOCAN)

HPV Infection | Lesion Cervix

Spain
Procare Health Iberia S.L.

Completed

Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction. (LIBIDOBS)

Female Sexual Dysfunction

Spain
PharmaMar
Apices Soluciones S.L.

Completed

Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 (APLICOV-PC)

COVID-19

Spain
PETHEMA Foundation
Cabyc, S.L.

Active, not recruiting

GEM-CLARIDEX: Ld vs BiRd (GEM-CLARIDEX)

Multiple Myeloma

Spain
Emory University
Insulcoud S.L.

Completed

A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes

Diabetes

United States
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.

Urinary Incontinence | Vaginal Atrophy | Vulvovaginal Signs and Symptoms | Dyspareunia

Bulgaria
Phytogen Medical Foods S.L.

Completed

Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™

Breast Cancer

Spain
Biomendi S.A.U.
Pivotal S.L.

Terminated

A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain

Postoperative Pain

Spain
ISDIN
Digna Biotech S.L.

Completed

Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study

Skin Fibrosis

United Kingdom, Spain, Italy, Poland, Germany, Hungary
Archivel Farma S.L.
Parexel

Completed

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

Tuberculosis | Latent Tuberculosis Infection

South Africa
ISDIN
Digna Biotech S.L.

Completed

Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers

Healthy

Spain
Esperion Therapeutics, Inc.

Recruiting

A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)

Hypercholesterolemia

United States, Spain, Denmark, Canada, Netherlands, Germany
Esperion Therapeutics, Inc.

Recruiting

Bempedoic Acid Pregnancy Surveillance Program

Pregnancy | Hyperlipidemias

United States
Esperion Therapeutics, Inc.

Completed

A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance

Hypercholesterolemia

United States
Esperion Therapeutics, Inc.

Completed

A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides

Dyslipidemia

United States
Esperion Therapeutics, Inc.

Completed

Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

United States
Esperion Therapeutics, Inc.

Completed

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk (CLEAR Wisdom)

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

United States
Esperion Therapeutics, Inc.

Completed

A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

Hyperlipidemias

United States
Esperion Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy

Hypercholesterolemia

United States
Esperion Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant (CLEAR Serenity)

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease | Statin Adverse Reaction

United States, Canada
Esperion Therapeutics, Inc.

Completed

A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

Hyperlipidemia

United States
Esperion Therapeutics, Inc.

Completed

Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002

Hyperlipidemia

United Kingdom
Esperion Therapeutics, Inc.

Completed

Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women

Healthy Lactating Women

United States
Esperion Therapeutics, Inc.

Completed

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Hypercholesterolemia | Atherosclerotic Cardiovascular Diseases

United States, United Kingdom, Germany, Poland, Netherlands, Canada
Esperion Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)

Atherosclerosis | Hypercholesterolemia | Statin Adverse Reaction

United States
Esperion Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

Hypercholesterolemia

United States
Esperion Therapeutics, Inc.

Completed

A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes

Type 2 Diabetes | Hyperlipidemia

United States
Esperion Therapeutics, Inc.

Completed

A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects

Safety Evaluation of Escalating Doses

United States

3

Subscribe